Arnold L. Oronsky, Director at KalVista Pharmaceuticals, Inc. (KALV), bought 58,824 shares at $17.00 ($1.0M) on 2018-09-10, disclosed to the SEC on 2018-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TSRO | BUY | 2016-03-18 | $10.0M | — | Filing → |
| AGTC | BUY | 2014-04-01 | $909K | — | Filing → |
| MKTO | SELL | 2014-03-03 | $1.0M | — | Filing → |